Showing results (131-140 of 1,009) with videos related to

Sort By:
Pageof 101
Cancer Research Communications|December 26, 2023
Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer-Treated with Neoadjuvant Systemic TherapyMaxim De Schepper, Ha-Linh Nguyen, François Richard, et al.
Cancer Research Communications|December 5, 2023
Discovery of KRB-456, a KRAS G12D Switch-I/II Allosteric Pocket Binder That Inhibits the Growth of Pancreatic Cancer Patient-derived TumorsAslamuzzaman Kazi, Alok Ranjan, Vasantha Kumar M V, et al.
Cancer Research Communications|December 18, 2023
Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United StatesEmily M Rencsok, Natalie Slopen, Hannah D McManus, et al.
Cancer Research Communications|December 19, 2023
FASN Gene Methylation is Associated with Fatty Acid Synthase Expression and Clinical-genomic Features of Prostate CancerOluwademilade Dairo, Lia DePaula Oliveira, Ethan Schaffer, et al.
Cancer Research Communications|December 20, 2023
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I StudyPamela Munster, Nicholas Iannotti, Daniel C Cho, et al.
Cancer Research Communications|December 19, 2023
Associations Between Serum Iron Biomarkers and Breast Cancer Tumor SizeAnn Von Holle, Rachel L Thompson, Katie M O'Brien, et al.
Cancer Research Communications|December 7, 2023
Signaling Pathway Alterations Driven by BRCA1 and BRCA2 Germline Mutations are Sufficient to Initiate Breast Tumorigenesis by the PIK3CAH1047R OncogenePoornima Bhat-Nakshatri, Aditi S Khatpe, Duojiao Chen, et al.
Cancer Research Communications|December 7, 2023
A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT TrialJosep Tabernero, Takayuki Yoshino, Sebastian Stintzing, et al.
Cancer Research Communications|January 5, 2024
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer CohortMakoto Nishio, Shuji Murakami, Hisato Kawakami, et al.
Cancer Research Communications|December 4, 2023
Inhibition of PRL2 Upregulates PTEN and Attenuates Tumor Growth in Tp53-deficient Sarcoma and Lymphoma Mouse ModelsFrederick Nguele Meke, Yunpeng Bai, Diego Ruiz-Avila, et al.
Pageof 101